Editorial Open Access
Copyright ©The Author(s) 1999. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jun 15, 1999; 5(3): 191-194
Published online Jun 15, 1999. doi: 10.3748/wjg.v5.i3.191
Escherichia Coli O157 : H7 and Shiga-like-toxin-producing Escherichia Coli in China
Jian-Guo Xu, Bo-Kun Cheng, Huai-Qi Jing, Key Laboratory of Molecular Medical Bacteriology, Ministry of Health, Institute of Epidemiology and Microbiology, Chinese Academy of Preventive Medicine, Beijing 102206, China
Jian-Guo Xu, male, born on 1952-04-19 in Pinglu County, Shanxi Province, graduated from Shanxi Medical University as a medical student in 1976, from Chinese Academy of Medical Sciences as graduate student with Master degree in 1982, from Chinese Academy of Preventive Medicine with doctoral degree in 1993, now professor of microbiology, majoring medical bacteriology, having 70 papers published.
Author contributions: All authors contributed equally to the work.
Supported by Outstanding Young Scientist Award from National Natural Science Foundation of China, Grant No. 39625001.
Correspondence to: Professor Jian-Guo Xu, Key Laboratory of Mo lecular Medical Bacteriology, Ministry of Health, Institute of Epidemiology and Microbiology, Chinese Academy for Preventive Medicine, Beijing 102206, China. xujg@public.bta.net.cn
Telephone: +86-10-61739579 Fax: +86-10-61730233
Received: February 5, 1999
Revised: March 22, 1999
Accepted: April 26, 1999
Published online: June 15, 1999

Abstract
Key Words: Escherichia coli O157:H7; Shiga-like-toxin; enteritis



TEXT

Escherichia coli (E. coli) is one of the facultative anaerobes of the human intestinal tract, usually harmless. Infections due to pathogenic E. coli may result in urinary tract infections, sepsis, meningitis and enteric disease. Diarrheagenic E. coli has been classified into several categories, such as entero-toxigenic E. coli (ETEC), entero-invasive E. coli (EIEC), entero-pathogenic E. coli (EPEC), entero-aggregative E. coli (EaggEC) and entero-hemorrhagic E. coli (EHEC). A variety of virulence or potential virulence factors for diarrheagenic E. coli have been identified. The nomenclature of diarrheagenic E. coli is based on virulence factors[1,2].

In 1977 Konowalchuk et al[3] reported that some strains of pathogenic E. coli O26 : H11 produced a toxin with a profound cytopathic effect on Vero cells, and named it verotoxin (VT). O’Brien et al[4] noted that the VT reported by Konowalchuk et al[3] was strikingly similar to Shiga toxin (Stx) produced by-Shigella dysenteriae type 1, and it could be neutralized by anti-Stx, thus a new nomenclature, Shiga-like toxin (SLT), appeared. An alternative nomenclature is “Shiga toxin” (ST), which indicated t hat the specific cytotoxin described by Konowalchuk et al[3] is esse ntially identical at the genetic and protein levels with the Stx produced by S. dysenteriae I discovered some 100 years ago. Consequently, SLT, ST and VT have been used interchangeably, resulting in the name of verotoxin- producing E. coli (VTEC), shiga-like-toxin-producing E. coli (SLTEC) and shiga-toxin-producing E. coli (STEC) coexisted in literature[5]. However, it must be noted that E. coli O157 : H7 is the main serotype of EHEC recognized at present[1,2,6]. Hemorrhagiccolitis (HC) and hemolytic uremic syndrome (HUS) are life threatening, which are often caused by STEC or EHEC. So far as the diseases are concerned, E. coli O157 : H7 should belong to EHEC. All of the EHEC strains are believed to be pathogenic. As for its toxin, E. coli O157 : H7 should belong to VTEC, SLTEC or STEC. However, not all of the STEC strains could cause HC or HUS[7]. The confusion from the nomenclature may be clarified in future when the pathogenic mechanisms of bacteria are fully understood.

Food-borne outbreaks of SLTEC disease appear to be increasing in the world. Mass-produced and mass-distributed food can involve large numbers of people in short time. SLTEC strains belong to a very diverse range of serotypes, among which O157 : H7 is most commonly associated with large outbreaks[8]. In the summer of 1996 in Japan, a largest outbreak in the world caused by E. coli O157 : H7 was reported, in which about 10000 cases were identified[9]. Chinese grovernment and society became aware of the importance of E. coli O157 : H7 from the Japanese outbreak. An informal national network for detection of E. coli O157 : H7 was organized in April 1997, involving about 30 public health laboratories from different provinces and municipalities.

E. coli O157 : H7 IN CHINA

The studies of E. coli O157 : H7 in China can be divided into two phases. In phase 1, starting from 1986 up to August 1996, the bacteriologists who studied the pathogen were mainly motivated by their scientific interests, few organized projects were carried out[2]. In phase 2, starting from August 1996 up to now, the public health authorities and most of the scientists have paid more attention to E. coli O157 : H7, and a new trend of isolation of E. coli O157 : H7 has been attempted in various parts of China.

The first group of patients with HC caused by E. coli O157 : H7 were identified in Beijing in 1988, as the etiologic agents isolated in Xuzhou city, Jiangsu Province of China[10]. In the three years from 1986 to 1988, 24 of 486 s poradic diarrhea patients were diagnosed as having HC, 5 strains of E. coli O157 : H7 were isolated, all of which were hybridized with SLT1, SLT2 and EHEC specific probe[10]. In 1993, two strains of E. coli O157 : H7 were isolated from a patient with HC and a patient with HUS, in Shandong Province. In the same period, several groups of scientists failed to isolate E. coli O157 : H7 in other cities of China, possibly due to lack of proper diagnostic techniques and reagents. Kain et al[11] reported that, in a study carried out in Beijing, about 7% of fecal samples were collected from diarrhea children hybridized with EHEC probe pCVD419 [6]. However, similar amount of positive samples were also observed in the control group, but without strain isolation. The 168 strains of EPEC isolated before 1982 were detected with SLT1, SLT2 and EHEC specific probes, no EHEC or STEC was found[2].

In 1997, a Chinese national network for detection of E. coli O157 : H7 was organized, E. coli O157 : H7 strains were isolated from diarrhea patients in Zhejiang, Anhui Provinces and Ningxia Autonomous Region. Nine strains were isolated from pigs in Fujian Province. It was interesting to note that all of the 9 strains from pig source were negative for SLT1, SLT2, and Hly genes. In 1998, several public health laboratories in China have attempted to isolate E. coli O157 : H7 from various sources, such as diarrhea patients, pigs, cattle, food and cow’s milk.A total of 48 strains were isolated from cattle, pigs and milk. Some strains were found to be hybridized with Hly, Slt1 or Slt2 gene probes, most of the strains, however, were not. And, this result was demonstrated and confirmed by PCR method in the reference laboratory. The E. coli O157 : H7 isolation data in China are summarized in Table 1.

Table 1 E. coli O157 : H7 strains isolated in China.
No. StrainsYearSourceHlyaSLT1SLT2Province
51986-1988HC+++Jiangsu
31993HC, HUS+++Shandong
11997Diarrhea+++Anhui
11997Diarrhea+--Zhejiang
11997Diarrhea+NDNDNingxia
11997Diarrhea---Passenger
91997Cattle---Fujian
21997Food+++Fujian
11998Milk+++Guangdong
21998FoodNDNDNDGuangdong
41998PigLiaoning
11998Cattle+++Liaoning
21998Cattle+NDNDHebei
141998CattleNDNDNDNingxia

It is shown in literature, that E. coli O157 : H7 strains have been isolated from samples of beef, lamb, deer, wild boar, ostrich, partridge, antelope, and reindeer[11,12]. Cattles have long been regarded as the principal reservoir of E. coli O157 : H7. STEC strains were found prevalent in the gastrointestinal tracts of other domestic animals, including sheep, pig, goat, dog, and cat[2,5]. Many domestic animals carrying pathogens are asymptomatic. Strains of E. coli O157 : H7 have also been detected in cats and dogs with diarrhea [2,5]. E. coli O157 : H7 can potentially enter the human food chain from a number of animal sources, most commonly by contamination of meat with feces or intestinal contents after slaughter. One of the most common sources of human E. coli O157 : H7 infections is hamburger patty, made from ground beef. Hence, most of the outbreaks of E. coli O157 : H7 infection all over the world have been linked to hamburgers. In the outbreak of United States in 1993, more than 700 people were infected, and over 50 cases of HUS were diagnosed. So far, this is the largest outbreak of E. coli O157 : H7 associated with hamburger.

In China, only few sporadic cases of E. coli O157 : H7 infections have been identified. No outbreak as yet has been reported. The strains of E. coli O157 : H7 were isolated from cattle, pigs and milk. These results suggest that risk of infection with these microbes existed in China. It occurred to us that the prevalence of E. coli O157 : H7 seems to be higher in pigs than one expected . It should be enphasized that the consumption of pork in China is very popular and the risk seems to be much higher than that from beef. Further investigation of E. coli O157 : H7 in pigs should be conducted in China. Fortunately, no known viru lence gene was found in the strains isolated from pigs in China such as SLT1, SL T2 and hemolysin gene as well. However, it was reported recently that the SLT2 containing phage from sewage, as the phage containing virulence gene, could infect non-pathogenic E. coli rather easily. The risk of such microbe infection seems fairly high.

SLTEC OTHER THAN O157 : H7 IN CHINA

E. coli O157 : H7 has not been recognized as a big public health problem in China up to now. However, STEC seems to be serious[13]. In clinical or public health bacteriological laboratories, only EPEC, ETEC and EIEC used to be diagnosed by serotyping techniques. Nevertheless, it has been noted not infrequently that almost pure cultures of E. coli were seen and new varieties of E. coli were isolated from certain fecal samples of diarrheal patients, which could not be serotyped with the typesera available . Whether they should be recognized as pathogenic E. coli or not still remains a question. We assumed that some of these strains isolated as E. coli might be pathogenic in nature, which had been overlooked because of lacking proper techniques for identification. In order to verify this hypothesis, we collected 174 named nonpathogenic E. coli strains in Beijing from 1988 to 1990 and detected them with DNA probes[14]. The DNA probes covered almost all the virulence genes reported, such as heat-stable toxin (ST) heat-labile toxin (LT), EPEC adherence factor (EAF), diffuse adherence gene (DA), EHEC specific probe pCVD419, EAggEC specific probe, 2.5 Kb specific probe for invasive plasmid (INV) of EIEC and Shigella-species, shig a-like toxin 1 or 2 (SLT1 or SLT2), EPEC attaching and effacing genes (eae). It was observed that 59.3% strains tested were hybridized with at least one of the used probes, with a higher percentage of (29.7%) E. coli strains hybridized with SLT2 and INV probes[13,14].

In general, strains of EHEC and some of EPEC hybridize with SLT1 or/and SLT2 probe. INV probe is a 2.5-Kb fragment derived from the invasive plasmid of S.flexneri 2a, and used as a diagnostic tool specific for Shigella species and EIEC strains[14,15]. The fragment was subsequently sequenced and named invasive associated locus (ial). However, none of the known EIEC or Shigella flexneria species was found to hybridize SLTs probes[16]. To cl arify the relationship between EIEC and some of our strains isolated, the invasive plasmid antigen BCD (ipaBCD), the key genes for invasive ability of EIEC and Shigella, were synthesized by PCR labeled by Digoxin and used as probe. The absence of DNA hybridization signals indicated a lack of ipaBCD genes in E. coli F171. We also found that E. coli F171 could not provok e keratoconjunctivitis in guinea pigs. Sereny test was used as a critical marker for virulence of EIEC and Shigella species. However, with HEp-2 cell assay, the E. coli F171 is able to invade the epithelial cells. The data suggested that the genes encodi ng invasive ability of E. coli-F171 differed from EIEC, and E. coli F171 was therefore not a member of EIEC[13,14].

Adherence of bacteria to epithelial cells has been recognized as a virulence characteristic of enteric pathogen[1]. Three adherence patterns were defined i.e., localized adherence, diffuse adherence and aggregative adherence[17]. Many of our E. coli strains hybridized with SLT2 and INV DNA probes demonstrated HEp-2 cell aggregative adherence pattern[13,14]. However, none of them were hybridized with EAggEC specific probe, which was derived from the genes encoding EAggEC adherence factor I (EAF/I), and used as an identific ation marker for EAggEC. The aggregative adherence pattern to HEp-2 cells is the characteristic feature as EAggEC strains[18]. Under electron microscope, a unique kind of fimbria was observed on the surface of cells of E. coli F171. The subunit size of the fimbriae protein was 19KDa, and the genes encoding the fimbriae were located on a 60 MDa plasmid . E. coli HB101 cells containing the cloned genes were able to adhere onto the HEp-2 cells. The analysis of N terminal amino acid sequence indicated that E. coli F171 has its unique features[14].

The shiga-like toxins have been demonstrated as the virulence factors for E. coli strain, which could cause HC and HUS[19]. Many of EPEC and EHEC strains contain genes for SLT1 or SLT2. The toxin producing ability of E. coli F171 was studied with Vero cell assay, which was originally used for study SLTs since E. coli F171 was hybridized with SLT2 probe. Both cell culture filtrate and a crude toxin preparation of E. coli F171 were found toxic to Vero cells. The Vero cell toxicity of E. coli F171 could not be neutralized by SLT2 antibody. The fact that hybridization of E. coli F171 with SLT2 probe suggested that it has DNA fragment homologous to SLT2 gene or it has an entire SLT2 gene[14].

The invasiveness, toxin production activity and epithelial cell adherence ability have been described as key features for EIEC, ETEC and EAggEC respectively[20]. E. coli F171 could adhere onto and invade into HEp-2 cells and produce toxins. It combines many key features of EIEC, EHEC, EPEC, and EAggEC. Based on the data obtained, it seems that E. coli F171 represents a new variety of STEC. Hence the name of enteric SLTs-producing and invasive E. coli (ESIEC) was proposed. Since 31.4% of collected E. coli strains were tested in our studies shared similar features as E. coli F171, infections presumably caused by this kind of pathogenic E. coli seems to be an important public health problem in China.

In order to confirm the virulence and pathogenesis to human beings, a study in adult volunteers was carried out. By oral in take of 109-1010 colony forming units (CFU) of E. coli F171, all of 8 volunteers developed diarrhea, 3 of 8 developed high fever (39.8 °C). The incubation period ranged from 7 to 49 h. Unformed stools were 3-6 times a day. The volumes of stools of 4 volunteers were above 1000 mL a day. Antibiotic therapy was given to 5 of the 8 volunteers. No diarrhea was observed for the control group consisting of 4 volunteers, who ingested 109 CFU of non-pathogenic strain E. coli-HB101. Typical clinical symptoms for ESIEC in volunteers were bowl movement, diarrhea, general abdominal pain, moderate fever and unformed stool. It was revealed that ingested E. coli F171 could colonize and replicate for up to 7 days. By examining the stool samples of the volunteers, it was observed that the bacteria could reach an amount of 2.74 × 1012 CFU. The strains isolated from the patient stool samples of volunteers were confirmed as E. coli F171 by specific antiserum in animal against it.

Although the human pathogenic nature of E. coli F171 was recognized, the key virulence factors of ESIEC have not been studied in detail. The pathogenic mechanism of ESIEC, for instance, has not been understood. The “pathogenicity island”, which refers to the large chromosomal segment carrying genes involved in pathogenicity, has recently revolutionized our understanding of bacterial pathogenesis[21]. The GC content of pathogenesity islands is different from that of the other host chromosome, suggesting that they may originate from horizontal transfer between different bacterial general. The number of gram-negative bacterial species known to harbor pathogenicity islands has grown steadily, including uropathogenic E. coli (UPEC), EHEC, EPEC, Helicobacter pylori, salmonella typhimurium and Vibrio cholerae[21]. It is believed that there is no pathogenicity island in the non-pathogenic E. coli. We must investigate the pathogenicity island so as to confirm the medical significance of ESIEC. Recently, we have observed an irp2 gene in many strains of ESIEC. The irp2 gene is involved in iron uptake and has been considered as one of the virulence genes located on the high pathogenecity island (HPI) of Yersinia-species[22]. This gene was observed in many strains of adherent E. coli and in E. coli isolated from blood, but rarely observed in EPEC, EIEC or ETEC. No-irp2-was found in EHEC, Shigella and Salmonella enterica strains. It seems that pathogenicity island existed in ESIEC. The HPI of the Y. pestis is disseminated among species of the Enterobacteriaceae family which are pathogenic to humans.

Footnotes

Edited by Jing-Yun Ma

References
1.  Levine MM. Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent. J Infect Dis. 1987;155:377-389.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 833]  [Cited by in F6Publishing: 853]  [Article Influence: 23.1]  [Reference Citation Analysis (0)]
2.  Xu JG, Qi GM. The clinical and epidemiological features of enterohemmorhagic E. coli and its diagnostic methods. Chin J Epidemiol. 1996;12:367-369.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Konowalchuk J, Speirs JI, Stavric S. Vero response to a cytotoxin of Escherichia coli. Infect Immun. 1977;18:775-779.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  O'Brien AD, Holmes RK. Shiga and Shiga-like toxins. Microbiol Rev. 1987;51:206-220.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Paton JC, Paton AW. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev. 1998;11:450-479.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Levine MM, Xu JG, Kaper JB, Lior H, Prado V, Tall B, Nataro J, Karch H, Wachsmuth K. A DNA probe to identify enterohemorrhagic Escherichia coli of O157: H7 and other serotypes that cause hemorrhagic colitis and hemolytic uremic syndrome. J Infect Dis. 1987;156:175-182.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 269]  [Cited by in F6Publishing: 247]  [Article Influence: 6.7]  [Reference Citation Analysis (0)]
7.  Xu J, Cheng B, Wu Y, Huang L, Deng Q, Lai X, Liu B. A new diarrhea pathogen: entero-adherent-invasive-toxigenic Escherichia coli. Chin Med J (Engl). 1996;109:16-17.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Griffin PM, Tauxe RV. The epidemiology of infections caused by Escherichia coli O157: H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev. 1991;13:60-98.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Fukushima H, Hashizume T, Kitani T. The massive outbreak of enterohemorrhagic E. coli O157 infections by food poisoning among the elementary school children in Sakai,Japan. 3rd Inter-national Symposium and Workshop on Shiga Toxin (Verotoxin) Producing Escherichia coli Infections. Melville, NY: Lois Joy Galler Foundation for Hemolytic Uremic Syndrome Inc. 1997;111.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Xu JG, Quan TS, Xiao DL, Fan RR, Li LM, Wang CA. Isolation and characterizati on of Escherichia coli O157 : H7 strains in China. Curr Microbiol. 1990;20:299-303.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 21]  [Cited by in F6Publishing: 21]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
11.  Kain KC, Barteluk RL, Kelly MT, He X, de Hua G, Ge YA, Proctor EM, Byrne S, Stiver HG. Etiology of childhood diarrhea in Beijing, China. J Clin Microbiol. 1991;29:90-95.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Clarke RC, Wilson JB, Read SC, Renwick S, Rahn K, Johnson RP. Verocytotoxin producing Escherichia coli (VTEC) in the food chain: preharvest and processing perspectives. In: Karmali, MA, Goglio AG eds. Recent advances in verocytotoxin producing Es-cherichia coli infections. Amsterdam. The Netherlands: Elsevier Science BV. 1994;17-24.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Xu JG, Cheng BQ, Wu YP, Huang LB, Lai XH, Liu BY, Lo XZ, Li HF. Adherence patterns and DNA probe types of Escherichia coli isolated from diarrheal patients in China. Microbiol Immunol. 1996;40:89-97.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Xu JG, Wu YP, Deng QD, Xiao HF, Hall R, Lai XH. Characteriza-tion of a Shiga -like toxin producing and invasive Escherichia coli strain: a possible new variety of diarrhaegenic pathogen. In: Keusch GT, Kawakami M, eds. Cytokines, cholera and the gut. OMN Ohmsha. Japan: IOS Press. 1996;321-328.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Small PL, Falkow S. Development of a DNA probe for the viru-lence plasmid of Shigella spp. and enteroinvasive Escherichia coli. In: Leive L, Bonventre PF, Morello JA, Silver SD, Wu WC, eds. Microbiology. Washington D.C: American Society for Microbiology. 1986;121-124.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Smith HR, Scotland SM, Chart H, Rowe B. Vero cytotoxin produc-tion and presence of VT genes in strains of Escherichia coli and Shigella. FEMS Microbiol Lett. 1987;42:173-177.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 30]  [Cited by in F6Publishing: 26]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
17.  Nataro JP, Kaper JB, Robins-Browne R, Prado V, Vial P, Levine MM. Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells. Pediatr Infect Dis J. 1987;6:829-831.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 437]  [Cited by in F6Publishing: 405]  [Article Influence: 10.9]  [Reference Citation Analysis (0)]
18.  Vial PA, Robins-Browne R, Lior H, Prado V, Kaper JB, Nataro JP, Maneval D, Elsayed A, Levine MM. Characterization of enteroadherent-aggregative Escherichia coli, a putative agent of diarrheal disease. J Infect Dis. 1988;158:70-79.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 241]  [Cited by in F6Publishing: 249]  [Article Influence: 6.9]  [Reference Citation Analysis (0)]
19.  Karmali MA. Infection by verocytotoxin-producing Escherichia coli. Clin Microbiol Rev. 1989;2:15-38.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev. 1998;11:142-201.  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Hacker J, Blum-Oehler G, Mühldorfer I, Tschäpe H. Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution. Mol Microbiol. 1997;23:1089-1097.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 795]  [Cited by in F6Publishing: 725]  [Article Influence: 26.9]  [Reference Citation Analysis (0)]
22.  Schubert S, Rakin A, Karch H, Carniel E, Heesemann J. Prevalence of the "high-pathogenicity island" of Yersinia species among Escherichia coli strains that are pathogenic to humans. Infect Immun. 1998;66:480-485.  [PubMed]  [DOI]  [Cited in This Article: ]